Errico Zupi

Medical therapies that suppress ovarian function are effective and alternative methods in pain-related relief of deep infiltrating endometriosis (DIE). The aim of this study was to assess whether the sonographically detectable posterior pel…

The aim of this study was to review the sonographic aspects of bladder endometriosis and to evaluate extension of the disease and associated symptoms. Fourteen patients with bladder endometriosis underwent sonographic evaluation prior to su…

OBJECTIVE: To assess and compare the laparoscopic uterine nerve ablation (LUNA) and the vaginal uterosacral ligament resection (VUSR) in postmenopausal women with chronic pelvic pain (CPP). STUDY DESIGN: Eighty postmenopausal women with in…

Magnetic Resonance Imaging (MRI) has emerged to be the best diagnostic imaging to evaluate the extent posterior pelvic deep infiltrating endometriosis (DIE). Two dimensional transvaginal sonography (2D TVS) shows some diagnostic limits in t…

Recently it has been reported that levonorgestrel intrauterine system could be an effective and safe method in the treatment of adenomyosis. The aim of this study is to assess whether the sonographic detectable morphological alterations of …

Pelvic pain associated with endometriosis is a common clinical problem. In approximately 20% of cases endometriosis-related pelvic pain is either minimally or not responsive to medical treatment; thus surgical treatment seems to be a valid …

STUDY OBJECTIVE: This study involved patients who, after laparoscopic surgery, had recurrence of endometriomas detected by sonography. The aim of this study was to evaluate the role of transvaginal sonography (TVS) in the management of recu…

To evaluate the accuracy of different sonographic approaches in the assessment of posterior site of deep endometriosis: pouch of Douglas, rectovaginal septum, uterosacral ligaments, vaginal wall, comparing sonographic findings with laparosc…

The aim of this study was to review the sonographic aspects of bladder endometriosis and to evaluate the extension of the disease and associated symptoms. Ten patients had a TVS diagnosis of infiltrative bladder endometriosis. Excision of t…

OBJECTIVE: To determine the efficacy of GnRH analogue plus add-back therapy compared with GnRH analogue alone and estroprogestin in patients with relapse of endometriosis-associated pain. DESIGN: Randomized, controlled study. SETTING: Uni…

OBJECTIVE: The aim of this study was to determine whether and to what extent laparoscopic removal of ovarian endometriotic cysts is a tissue-sparing procedure. STUDY DESIGN: At the University Hospital, 77 women of reproductive age with end…

STUDY OBJECTIVE: To assess the long-term effectiveness of presacral neurectomy (PSN) in women with severe dysmenorrhea due to endometriosis treated with conservative laparoscopic surgical intervention. DESIGN: Randomized, controlled trial …

The aim of this study was to evaluate the role of transvaginal sonography (TVS) in the detection and follow-up of recurrence of ovarian endometriomas after laparoscopic removal. We studied 62 patients in fertile age who underwent laparoscop…

OBJECTIVE: The purpose of this study was to assess the effectiveness of presacral neurectomy in women with severe dysmenorrhea caused by endometriosis that was treated with conservative surgical intervention. STUDY DESIGN: One hundred fort…

Zullo, Fulvio; Palomba, Stefano; Zupi, Errico; Russo, Tiziana; Morelli, Michele; Capppiello, Fulvio; Mastrantonio, Pasquale

STUDY OBJECTIVE: To evaluate the advantages and accuracy of hysterosalpingo-contrast sonography (HyCoSy) in assessing tubal patency compared with hysterosalpingogram (HSG) and laparoscopic dye pertubation. DESIGN: Prospective study (Canadi…

STUDY OBJECTIVE: To estimate whether laparoscopic staging of endometriosis can be predicted by ultrasound findings. DESIGN: Prospective study (Canadian Task Force classification II-2). SETTING: Obstetrics and Gynecology Department, Univer…

OBJECTIVE: This is a randomized clinical trial comparing estroprogestin (E/P) pill given for 12 months vs. gonadotrophin releasing hormone agonist (GNRHa) given for 4 months followed by E/P pill treatment for 8 months in the relief of endom…